B S Katzenellenbogen - JoVE Visualize

Showing results (91-100 of 168) with videos related to

Pageof 17

Sort By:

Cancer Research|August 15, 1987

Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogensB S Katzenellenbogen, K L Kendra, M J Norman, et al.

Journal of Steroid Biochemistry|July 1, 1983

Antiestrogen pharmacology and mechanism of actionB S Katzenellenbogen, M A Miller, R L Eckert, et al.

Journal of Medicinal Chemistry|February 1, 1982

Antiestrogen basicity--activity relationships: a comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogues of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (tamoxifen, Nolvadex) having altered basicityD W Robertson, J A Katzenellenbogen, J R Hayes, et al.

The Journal of Biological Chemistry|February 11, 1994

Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activityP Le Goff, M M Montano, D J Schodin, et al.

Endocrinology|August 1, 1995

Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptorsB A Ince, D J Schodin, D J Shapiro, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 17, 1996

Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivatorE M McInerney, M J Tsai, B W O'Malley, et al.

Endocrinology|June 29, 1999

Estrogen receptor regulation of the Na+/H+ exchange regulatory factorT R Ediger, W L Kraus, E J Weinman, et al.

Cancer Research|September 1, 1985

Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cellsY Y Sheen, T S Ruh, W F Mangel, et al.

Molecular Endocrinology (Baltimore, Md.)|December 1, 1996

A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen actionE M McInerney, B A Ince, D J Shapiro, et al.

The Journal of Biological Chemistry|March 25, 1981

Interaction of a high affinity anti-estrogen (alpha-[4-pyrrolidinoethoxy]phenyl-4-hydroxy-alpha'-nitrostilbene, CI628M) with uterine estrogen receptorsB S Katzenellenbogen, E J Pavlik, D W Robertson, et al.

Pageof 17

Showing results (91-100 of 168) with videos related to

Sort By:

Pageof 17

Cancer Research|August 15, 1987

Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogensB S Katzenellenbogen, K L Kendra, M J Norman, et al.

Journal of Steroid Biochemistry|July 1, 1983

Antiestrogen pharmacology and mechanism of actionB S Katzenellenbogen, M A Miller, R L Eckert, et al.

Journal of Medicinal Chemistry|February 1, 1982

Antiestrogen basicity--activity relationships: a comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogues of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (tamoxifen, Nolvadex) having altered basicityD W Robertson, J A Katzenellenbogen, J R Hayes, et al.

The Journal of Biological Chemistry|February 11, 1994

Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activityP Le Goff, M M Montano, D J Schodin, et al.

Endocrinology|August 1, 1995

Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptorsB A Ince, D J Schodin, D J Shapiro, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 17, 1996

Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivatorE M McInerney, M J Tsai, B W O'Malley, et al.

Endocrinology|June 29, 1999

Estrogen receptor regulation of the Na+/H+ exchange regulatory factorT R Ediger, W L Kraus, E J Weinman, et al.

Cancer Research|September 1, 1985

Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cellsY Y Sheen, T S Ruh, W F Mangel, et al.

Molecular Endocrinology (Baltimore, Md.)|December 1, 1996

A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen actionE M McInerney, B A Ince, D J Shapiro, et al.

The Journal of Biological Chemistry|March 25, 1981

Interaction of a high affinity anti-estrogen (alpha-[4-pyrrolidinoethoxy]phenyl-4-hydroxy-alpha'-nitrostilbene, CI628M) with uterine estrogen receptorsB S Katzenellenbogen, E J Pavlik, D W Robertson, et al.

Pageof 17